Your session is about to expire
← Back to Search
PLDR Radiation for Pancreatic Cancer
Study Summary
This trial is testing a new type of radiation therapy called pulsed low-dose rate (PLDR) radiation in combination with the chemotherapeutic drug gemcitabine given weekly along with the radiation.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- You have not received any treatment for pancreatic cancer, except for chemotherapy.You are not physically able to have a major surgery right now.You need to have a way for the doctors to measure your disease using specific criteria.Your cancer has spread to other parts of your body and has been confirmed by imaging or tissue tests.You have a history of ataxia telangiectasia or being very sensitive to radiation.You have scleroderma or another ongoing connective tissue disease.You have ongoing inflammatory bowel disease.You have a severe infection that needs to be treated with antibiotics given through a vein.Patients must have a confirmed diagnosis of pancreatic adenocarcinoma through tissue or cell testing.The doctor thinks you should have chemotherapy and radiation before surgery for medical reasons.You are able to carry out everyday activities without any help or with some limitations.Your bone marrow, liver, and kidneys are working well.Your white blood cell count is at least 1,500 per milliliter and your platelet count is at least 100,000 per milliliter.Your bilirubin levels are within a certain range.Your AST and ALT liver enzyme levels are not more than three times the upper limit of normal.Your serum creatinine level is not more than 1.5 times the upper limit of normal.
- Group 1: PLDR Chemoradiation
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Are there any openings for volunteers in this experiment currently?
"Affirmative. Clinical trials' records on clinicaltrials.gov demonstrate that this medical experiment, which was first published on January 13th 2020, is actively recruiting individuals for participation. 12 patients need to be enlisted from a single trial centre."
Could you provide a numerical estimate of the participants for this clinical research?
"Affirmative. According to the clinicaltrials.gov, this trial is engaging participants. It was first advertised on 13th January 2020 and updated most recently on 18th July 2022; they are recruiting 12 individuals from a single location."
Share this study with friends
Copy Link
Messenger